祛脂乙酯和氯苯丁酯对抗凝需求的影响。 - Suppr

Suppr

超能文献

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

作者信息

OLIVER M F, ROBERTS S D, HAYES D, PANTRIDGE J F, SUZMAN M M, BERSOHN I

出版信息

Lancet. 1963 Jan 19;1(7273):143-4. doi: 10.1016/s0140-6736(63)91025-0.

DOI:10.1016/s0140-6736(63)91025-0

PMID:13940003

Abstract

摘要

相似文献

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

Lancet. 1963 Jan 19;1(7273):143-4. doi: 10.1016/s0140-6736(63)91025-0.

A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.

Med J Aust. 1965 Jul 31;2(5):192-4.

AGRANULOCYTOSIS DURING ADMINISTRATION OF "ATROMID".

Br Med J. 1963 Aug 31;2(5356):543-4. doi: 10.1136/bmj.2.5356.543.

[ATROMID IN HYPERCHOLESTEROLEMIA AND HYPERLIPEMIA. LITERATURE REVIEW AND RESULTS OF CLINICAL TESTS].

Sven Lakartidn. 1964 Apr 29;61:1446-57.

CLINICAL OBSERVATIONS ON PATIENTS TREATED WITH ATROMID AND ANTICOAGULANTS.

J Atheroscler Res. 1963 Sep-Dec;3:671-6. doi: 10.1016/s0368-1319(63)80051-4.

[EFFECT OF DEHYDROEPIANDROSTERONE AND ATROMID ON SERUM LIPIDS IN PATIENTS WITH HYPERCHOLESTEREMIA OR HYPERTRIGLYCERIDEMIA].

Cas Lek Cesk. 1965 Feb 19;104:186-9.

EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE WITH OR WITHOUT ANDROSTERONE ON PLATELET STICKINESS.

Lancet. 1964 Aug 1;2(7353):233-4. doi: 10.1016/s0140-6736(64)90184-9.

ATROMID AND ANTICOAGULANT THERAPY.

J Atheroscler Res. 1963 Sep-Dec;3:658-70. doi: 10.1016/s0368-1319(63)80050-2.

THE TREATMENT OF XANTHOMATOSIS WITH ATROMID.

Br J Dermatol. 1964 Feb;76:53-5. doi: 10.1111/j.1365-2133.1964.tb14474.x.

THE RESPONSE OF HYPERLIPOPROTEINEMIAS TO ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE.

J Atheroscler Res. 1963 Sep-Dec;3:445-53. doi: 10.1016/s0368-1319(63)80024-1.

引用本文的文献

AGRANULOCYTOSIS DURING ADMINISTRATION OF "ATROMID".

Br Med J. 1963 Aug 31;2(5356):543-4. doi: 10.1136/bmj.2.5356.543.

Warfarin potentiation with bezafibrate.

Postgrad Med J. 1997 Oct;73(864):657-8. doi: 10.1136/pgmj.73.864.657.

Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).

Postgrad Med J. 1965 Sep;41(479):563-5. doi: 10.1136/pgmj.41.479.563.

Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).

Trans Am Clin Climatol Assoc. 1968;79:216-28.

Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.

Experientia. 1974 May 15;30(5):460-1. doi: 10.1007/BF01926292.

Adverse effects of hypolipidaemic drugs.

Med Toxicol. 1987 Jan-Feb;2(1):10-32. doi: 10.1007/BF03259858.

Drug interactions that matter. A critical reappraisal.

Drugs. 1988 Jul;36(1):83-110. doi: 10.2165/00003495-198836010-00006.

Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):109-11. doi: 10.1177/00359157760690S229.

Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.

J Pharmacokinet Biopharm. 1977 Oct;5(5):495-505. doi: 10.1007/BF01061730.

Drug interactions and clinical pharmacokinetics.

Clin Pharmacokinet. 1976;1(5):351-72. doi: 10.2165/00003088-197601050-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

作者信息

OLIVER M F, ROBERTS S D, HAYES D, PANTRIDGE J F, SUZMAN M M, BERSOHN I

出版信息

Lancet. 1963 Jan 19;1(7273):143-4. doi: 10.1016/s0140-6736(63)91025-0.

DOI:10.1016/s0140-6736(63)91025-0

PMID:13940003

Abstract

摘要

相似文献

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

Lancet. 1963 Jan 19;1(7273):143-4. doi: 10.1016/s0140-6736(63)91025-0.

A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.

Med J Aust. 1965 Jul 31;2(5):192-4.

AGRANULOCYTOSIS DURING ADMINISTRATION OF "ATROMID".

Br Med J. 1963 Aug 31;2(5356):543-4. doi: 10.1136/bmj.2.5356.543.

[ATROMID IN HYPERCHOLESTEROLEMIA AND HYPERLIPEMIA. LITERATURE REVIEW AND RESULTS OF CLINICAL TESTS].

Sven Lakartidn. 1964 Apr 29;61:1446-57.

CLINICAL OBSERVATIONS ON PATIENTS TREATED WITH ATROMID AND ANTICOAGULANTS.

J Atheroscler Res. 1963 Sep-Dec;3:671-6. doi: 10.1016/s0368-1319(63)80051-4.

[EFFECT OF DEHYDROEPIANDROSTERONE AND ATROMID ON SERUM LIPIDS IN PATIENTS WITH HYPERCHOLESTEREMIA OR HYPERTRIGLYCERIDEMIA].

Cas Lek Cesk. 1965 Feb 19;104:186-9.

EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE WITH OR WITHOUT ANDROSTERONE ON PLATELET STICKINESS.

Lancet. 1964 Aug 1;2(7353):233-4. doi: 10.1016/s0140-6736(64)90184-9.

ATROMID AND ANTICOAGULANT THERAPY.

J Atheroscler Res. 1963 Sep-Dec;3:658-70. doi: 10.1016/s0368-1319(63)80050-2.

THE TREATMENT OF XANTHOMATOSIS WITH ATROMID.

Br J Dermatol. 1964 Feb;76:53-5. doi: 10.1111/j.1365-2133.1964.tb14474.x.

THE RESPONSE OF HYPERLIPOPROTEINEMIAS TO ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE.

J Atheroscler Res. 1963 Sep-Dec;3:445-53. doi: 10.1016/s0368-1319(63)80024-1.

引用本文的文献

AGRANULOCYTOSIS DURING ADMINISTRATION OF "ATROMID".

Br Med J. 1963 Aug 31;2(5356):543-4. doi: 10.1136/bmj.2.5356.543.

Warfarin potentiation with bezafibrate.

Postgrad Med J. 1997 Oct;73(864):657-8. doi: 10.1136/pgmj.73.864.657.

Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).

Postgrad Med J. 1965 Sep;41(479):563-5. doi: 10.1136/pgmj.41.479.563.

Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).

Trans Am Clin Climatol Assoc. 1968;79:216-28.

Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.

Experientia. 1974 May 15;30(5):460-1. doi: 10.1007/BF01926292.

Adverse effects of hypolipidaemic drugs.

Med Toxicol. 1987 Jan-Feb;2(1):10-32. doi: 10.1007/BF03259858.

Drug interactions that matter. A critical reappraisal.

Drugs. 1988 Jul;36(1):83-110. doi: 10.2165/00003495-198836010-00006.

Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.

Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):109-11. doi: 10.1177/00359157760690S229.

Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.

J Pharmacokinet Biopharm. 1977 Oct;5(5):495-505. doi: 10.1007/BF01061730.

Drug interactions and clinical pharmacokinetics.

Clin Pharmacokinet. 1976;1(5):351-72. doi: 10.2165/00003088-197601050-00003.